Concomitant Methotrexate Protects Against Total Knee Arthroplasty in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors.

CONCLUSION: Concomitant MTX reduces the incidence of TKA by 56% in patients with RA during longterm treatment with TNF inhibitors.
PMID: 26428206 [PubMed - as supplied by publisher]

Source: J Rheumatol - October 1, 2015 Category: Rheumatology Authors: Asai S, Takahashi N, Funahashi K, Yoshioka Y, Takemoto T, Terabe K, Asai N, Ishiguro N, Kojima T Tags: J Rheumatol Source Type: research